Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Federal Funds Might Ease Cost Increases In States' Rx Assistance Programs

Executive Summary

The New Jersey PAAD drug assistance program has seen program costs increase by more than 20% over the past three years despite a decline in enrollment, Pharmaceutical Assistance to the Aged and Disabled Program Director Kathleen Mason said.

You may also be interested in...

Maine Rx Pricing Law Seeks FSS-Level Prices By October 2001

The "Maine Rx" discount law seeks Federal Supply Schedule-level rebates for prescriptions filled in Maine by October 2001.

Medicare Rx Block Grant Approach Viewed Skeptically By Penn. Gov. Ridge

State governors are wary of proposals to use a federal block grant approach to provide a prescription drug benefit for the elderly, Pennsylvania Gov. Thomas Ridge (R) told the Pharmaceutical Research & Manufacturers of America annual meeting April 15 in Laguna Niguel, Calif.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts